Breckenridge announces final FDAapproval for Everolimus tablets for oralsuspension, AB-rated to AFINITORDISPERZ ®
Berkeley Heights, New Jersey, January 29, 2025 Breckenridge Pharmaceutical, Inc.,-the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, – announced today that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral Suspension (TFOS), 2mg, 3mg and 5mg, a generic version of […]
